The life sciences industry is at a turning point in corporate communications. Treating Investor Relations (IR) and External Communications (EC) as separate functions no longer meets the demands of today’s complex stakeholder landscape. Investors expect consistent narratives aligned with public positioning, media outlets seek compelling yet scientifically accurate stories, and regulators require compliance across all channels.
This white paper introduces a practical framework for integrating IR and EC into a unified approach. You’ll learn why integration is critical, the challenges companies face, and how to operationalize effective strategies that ensure message consistency, regulatory compliance, and stakeholder engagement.
What you'll learn:
- Why life sciences companies must unify Investor Relations (IR) and External Communications (EC) to meet investor, media, and regulatory expectations.
- How to operationalize integrated IREC through a phased roadmap, covering foundational audits, channel-specific messaging, execution strategies, and optimization strategies.
- Lessons from successful implementations, including IPO preparation, funding milestone communications, and product launches.
Discover how integrated communications can become your competitive advantage
Explore more resources
Risk-Sharing Contracts: Mainstream or Niche?
Kris Kang, VP, Access Experience Team
Optimizing Access: Why Early, External Insight Is Critical to Commercial Success
Dominic Galante, MD and Ross Maclean, MD In the biopharma and MedTech sectors, the development pathway for a new...
What Happens When HCPs get the Right Message
What happens when healthcare providers receive the right message at the right time? In today’s competitive...